Skip to main content

Double blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low dose oral prednisolone in Pityriasis Rosea<sup/>.

Author
Abstract
:

To evaluate the efficacy and safety of short-course low-dose oral prednisolone in symptomatic pityriasis rosea (PR) of onset less than 5 days and compare it with placebo.

Year of Publication
:
2018
Journal
:
The Journal of dermatological treatment
Number of Pages
:
1-23
Date Published
:
2018
ISSN Number
:
0954-6634
URL
:
http://www.tandfonline.com/doi/full/10.1080/09546634.2018.1430302
DOI
:
10.1080/09546634.2018.1430302
Short Title
:
J Dermatolog Treat
Download citation